COVID-19: Up to 82% critically ill patients had low Vitamin C values

Abstract

Abstract There are limited proven therapeutic options for the prevention and treatment of COVID-19. We underwent an observational study with the aim of measure plasma vitamin C levels in a population of critically ill COVID-19 adult patients who met ARDS criteria according to the Berlin definition. This epidemiological study brings to light that up to 82% had low Vitamin C values. Notwithstanding the limitation that this is a single-center study, it nevertheless shows an important issue. Given the potential role of vitamin C in sepsis and ARDS, there is gathering interest of whether supplementation could be beneficial in COVID-19.

Keywords

• COVID-19
• SARS-CoV-2
• Vitamin C
• ARDS
• ICU
• Critically ill patient